Senior insider sale
See "Remarks" at TEVA PHARMACEUTICAL INDUSTRIES LTD — senior position signals high conviction
$6.92M
206.28K shares
What this filing means
SABAG MARK plans to sell 206.28K shares of TEVA PHARMACEUTICAL INDUSTRIES LTD valued at approximately $6.92M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/4/2026ACC: 0001973379-26-000154
Officer· See "Remarks"
Since Mar 2026
206.28K
Shares to sell
$6.92M
Approx. market value
144.18K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
SHARES FROM ROLLOVER
COMPENSATION
3/4/2026
33.51KSHARES FROM ROLLOVER
COMPENSATION
3/3/2026
110.67KTotal acquired144.18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2026 | SHARES FROM ROLLOVER COMPENSATION | 33.51K | — |
3/3/2026 | SHARES FROM ROLLOVER COMPENSATION | 110.67K | — |
| Total | 144.18K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
62.10K
Market value
$1.87M
3/17/2026
Planned — Approximate Date
NYSEPlanned
Units to sell
144.18K
Market value
$5.05M
5/1/2026
Total
Units
206.28K
Value
$6.92M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/17/2026 | 62.10K | $1.87M | — | Completed |
| Planned — Approximate Date | ||||
5/1/2026 | 144.18K | $5.05M | NYSE | Planned |
| Total | 206.28K | $6.92M | ||